[
  {
    "ts": null,
    "headline": "Incyte Corp. stock outperforms competitors on strong trading day",
    "summary": "Incyte Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=81465569b24f5cd7618bfbbf2001e7ed1a2de94eb50c76ef4a12c67ccb667b6d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732554900,
      "headline": "Incyte Corp. stock outperforms competitors on strong trading day",
      "id": 131632469,
      "image": "",
      "related": "INCY",
      "source": "MarketWatch",
      "summary": "Incyte Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=81465569b24f5cd7618bfbbf2001e7ed1a2de94eb50c76ef4a12c67ccb667b6d"
    }
  },
  {
    "ts": null,
    "headline": "Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting",
    "summary": "WILMINGTON, Del., November 25, 2024--Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting",
    "url": "https://finnhub.io/api/news?id=d2fd29cd32916120782ae995cda3333249b41d2e39b4330a5c0999fe6b17869d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732547340,
      "headline": "Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting",
      "id": 131639458,
      "image": "https://media.zenfs.com/en/business-wire.com/da7813c24b8a5b0fd0f19158d36c9b59",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del., November 25, 2024--Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting",
      "url": "https://finnhub.io/api/news?id=d2fd29cd32916120782ae995cda3333249b41d2e39b4330a5c0999fe6b17869d"
    }
  }
]